4.7 Article

Effects of Chitin and Sepia Ink Hybrid Hemostatic Sponge on the Blood Parameters of Mice

期刊

MARINE DRUGS
卷 12, 期 4, 页码 2269-2281

出版社

MDPI
DOI: 10.3390/md12042269

关键词

chitin; sepia ink; coagulation; anticoagulation; fibrinolytic; hemorheology

资金

  1. Spark Program of the State Ministry of Science Technology [2012GA780020]
  2. project of Scientific and Technological Cooperation and the Exchange Program in Guangxi Province [1346011-25]
  3. special fund project of industry, university and research institute collaboration in Guangdong province [2011B090400274]
  4. project of Science & Technology in Zhanjiang city [2011D0244, 2013A202-4]
  5. Science & Technology Plan in Zhanjiang Normal University [QL1306, ZL1313]

向作者/读者索取更多资源

Chitin and sepia ink hybrid hemostatic sponge (CTSH sponge), a new biomedical material, was extensively studied for its beneficial biological properties of hemostasis and stimulation of healing. However, studies examining the safety of CTSH sponge in the blood system are lacking. This experiment aimed to examine whether CTSH sponge has negative effect on blood systems of mice, which were treated with a dosage of CTSH sponge (135 mg/kg) through a laparotomy. CTSH sponge was implanted into the abdominal subcutaneous and a laparotomy was used for blood sampling from abdominal aortic. Several kinds of blood parameters were detected at different time points, which were reflected by coagulation parameters including thrombin time (TT), prothrombin time (PT), activated partial thromboplatin time (APTT), fibrinogen (FIB) and platelet factor 4 (PF4); anticoagulation parameter including antithrombin III (AT-III); fibrinolytic parameters including plasminogen (PLG), fibrin degradation product (FDP) and D-dimer; hemorheology parameters including blood viscosity (BV) and plasma viscosity (PV). Results showed that CTSH sponge has no significant effect on the blood parameters of mice. The data suggested that CTSH sponge can be applied in the field of biomedical materials and has potential possibility to be developed into clinical drugs of hemostatic agents.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据